Value-Based Pricing and Reimbursement in Personalised Healthcare: Introduction to the Basic Health Economics

by Louis P. Garrison, Adrian Towse
Published 2017-09-01

Establishing a reasonable price for an orphan drug

by Mikel Berdud, Michael Drummond, Adrian Towse
Published 2020-09-01

Market-driven, value-based, advance commitment (MVAC): accelerating the development of a pathbreaking universal drug regimen to end TB

by Rachel Silverman, Adrian Towse, Martina Garau, Ganesh Ramakrishnan
Published 2020-04-01

Reconciling ACEA and MCDA: is there a way forward for measuring cost-effectiveness in the U.S. healthcare setting?

by Bernarda Zamora, Louis P. Garrison, Aig Unuigbe, Adrian Towse
Published 2021-03-01

Understanding the Economic Value of Molecular Diagnostic Tests: Case Studies and Lessons Learned

by Adrian Towse, Diego Ossa, David Veenstra, Josh Carlson, Louis Garrison
Published 2013-10-01

Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi‐stakeholder, international workshop

by Nicholas. R Latimer, Daniel Pollard, Adrian Towse, Chris Henshall, Lloyd Sansom, Robyn L Ward, Andrew Bruce, Carla Deakin
Published 2021-05-01